| Advertisement Name : |
WALK-IN INTERVIEW ON 03.07.2026, Reporting Time: 09:30 A.M. TO 10:30 A.M.
Required “Clinical Research Coordinator (Multitask Coordinator)”for “A global, multicenter, three arms, open-label randomized study to evaluate the efficacy and safety of Nanosomal Docetaxel Lipid Suspension compared to Taxotere® (Docetaxel Injection Concentrate) in triple-negative breast cancer patients with locally advanced or metastatic breast cancer after failure to prior chemotherapy.”Project(initially for a period of 6 months) at IRB Monitoring Room, 3rd Floor, Main Building, Dr. E. Borges Marg, Parel, Mumbai – 400012,
|